| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TOX.2009.10.004 |
| P698 | PubMed publication ID | 19822182 |
| P50 | author | Michael P. Waalkes | Q113460555 |
| P2093 | author name string | Hongzu Ren | |
| J Christopher Corton | |||
| Don A Delker | |||
| Kirk T Kitchin | |||
| James W Allen | |||
| Bhalchandra A Diwan | |||
| Gail M Nelson | |||
| Gene J Ahlborn | |||
| Geremy Knapp | |||
| P2860 | cites work | Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2·Keap1·Cul3 complex and recruiting Nrf2·Maf to the antioxidant response element enhancer | Q23923854 |
| The molecular mechanisms of arsenic-induced cell transformation and apoptosis | Q24812452 | ||
| Assessing susceptibility from early-life exposure to carcinogens | Q24815464 | ||
| Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure | Q25256866 | ||
| Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? | Q26345064 | ||
| Cancer chemoprevention by ginseng in mouse liver and other organs | Q28366721 | ||
| Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia | Q28370464 | ||
| Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile | Q28389177 | ||
| Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood | Q28390288 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR | Q28513664 | ||
| Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats | Q28578674 | ||
| ATP-citrate lyase links cellular metabolism to histone acetylation | Q29615367 | ||
| Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan | Q80270327 | ||
| S-adenosyl-L-methionine counteracts mitotic disturbances and cytostatic effects induced by sodium arsenite in HeLa cells | Q81338228 | ||
| Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites | Q82095301 | ||
| Histone acetylation and cancer | Q33632377 | ||
| Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. | Q33694520 | ||
| Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models | Q33942505 | ||
| Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 | ||
| Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity | Q33960868 | ||
| Pharmacokinetics, metabolism, and carcinogenicity of arsenic | Q34236890 | ||
| Identification of potential caloric restriction mimetics by microarray profiling | Q34454584 | ||
| The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects | Q34581717 | ||
| Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients | Q34739789 | ||
| Evidence that arsenite acts as a cocarcinogen in skin cancer | Q35846851 | ||
| Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent | Q36089482 | ||
| Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity | Q36372954 | ||
| Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice | Q36393258 | ||
| Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis | Q36557194 | ||
| Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus | Q36971092 | ||
| Liver diseases and metabolic syndrome | Q37224466 | ||
| Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression. | Q40214713 | ||
| Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis | Q40251813 | ||
| Extracts of Rehmanniae radix, Ginseng radix and Scutellariae radix improve glucose-stimulated insulin secretion and beta-cell proliferation through IRS2 induction | Q40734941 | ||
| Genetics of liver tumor susceptibility in mice. | Q40967225 | ||
| Regulation of the expression of lipogenic enzyme genes by carbohydrate | Q41548602 | ||
| Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance | Q42506602 | ||
| Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation | Q43003956 | ||
| Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice | Q44313185 | ||
| Global alteration of gene expression in human keratinocytes by inorganic arsenic | Q44427338 | ||
| Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers | Q44599839 | ||
| Induction of structural and numerical changes of chromosome, centrosome abnormality, multipolar spindles and multipolar division in cultured Chinese hamster V79 cells by exposure to a trivalent dimethylarsenic compound. | Q44620655 | ||
| Aneuploidy acts both oncogenically and as a tumor suppressor | Q44738012 | ||
| Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis | Q44790857 | ||
| Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis | Q44836543 | ||
| Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice | Q44994681 | ||
| Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone | Q45220833 | ||
| Use of microarray biomarkers to identify longevity therapeutics | Q46101205 | ||
| Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma | Q46470997 | ||
| Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression | Q46487303 | ||
| Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin | Q46598627 | ||
| The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. | Q46614897 | ||
| Case-control study of bladder cancer and arsenic in drinking water | Q46809950 | ||
| Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment | Q46923177 | ||
| Exposure to arsenic at levels found inU.S. drinking water modifies expression in the mouse lung. | Q50941383 | ||
| Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. | Q50981303 | ||
| Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. | Q51665999 | ||
| Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. | Q53408366 | ||
| Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol. | Q53415046 | ||
| Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice | Q63859562 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6-15 | |
| P577 | publication date | 2009-10-12 | |
| P1433 | published in | Toxicology | Q1666328 |
| P1476 | title | Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic | |
| P478 | volume | 266 |
| Q64945501 | Aberrant lipid metabolism as a therapeutic target in liver cancer. |
| Q24707869 | Carcinogenic Effects of “Whole-Life” Exposure to Inorganic Arsenic in CD1 Mice |
| Q36083539 | Developmental exposure to 50 parts-per-billion arsenic influences histone modifications and associated epigenetic machinery in a region- and sex-specific manner in the adult mouse brain |
| Q34371580 | Evaluation of the carcinogenicity of inorganic arsenic |
| Q26799414 | In utero arsenic exposure in mice and early life susceptibility to cancer |
| Q37769295 | Oxygenomics in environmental stress. |
Search more.